- Home
- INTT vs IMAB Comparison
INTT vs IMAB Comparison
Compare INTT & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTT
- IMAB
- Stock Information
- Founded
- INTT 1981
- IMAB 2014
- Country
- INTT United States
- IMAB United States
- Employees
- INTT N/A
- IMAB N/A
- Industry
- INTT Semiconductors
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- INTT Technology
- IMAB Health Care
- Exchange
- INTT Nasdaq
- IMAB Nasdaq
- Market Cap
- INTT 77.3M
- IMAB 73.9M
- IPO Year
- INTT 1997
- IMAB 2020
- Fundamental
- Price
- INTT $6.00
- IMAB $0.85
- Analyst Decision
- INTT Strong Buy
- IMAB Strong Buy
- Analyst Count
- INTT 2
- IMAB 2
- Target Price
- INTT $16.00
- IMAB $5.50
- AVG Volume (30 Days)
- INTT 44.5K
- IMAB 261.6K
- Earning Date
- INTT 05-02-2025
- IMAB 04-03-2025
- Dividend Yield
- INTT N/A
- IMAB N/A
- EPS Growth
- INTT N/A
- IMAB N/A
- EPS
- INTT 0.24
- IMAB N/A
- Revenue
- INTT $130,690,000.00
- IMAB N/A
- Revenue This Year
- INTT $6.67
- IMAB N/A
- Revenue Next Year
- INTT $6.66
- IMAB N/A
- P/E Ratio
- INTT $25.22
- IMAB N/A
- Revenue Growth
- INTT 5.99
- IMAB N/A
- 52 Week Low
- INTT $5.24
- IMAB $0.60
- 52 Week High
- INTT $12.28
- IMAB $2.00
- Technical
- Relative Strength Index (RSI)
- INTT 34.90
- IMAB 53.01
- Support Level
- INTT $5.51
- IMAB $0.63
- Resistance Level
- INTT $6.15
- IMAB $1.01
- Average True Range (ATR)
- INTT 0.42
- IMAB 0.10
- MACD
- INTT 0.00
- IMAB 0.02
- Stochastic Oscillator
- INTT 39.38
- IMAB 60.39
About INTT inTest Corporation
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).